Skip to main content
Cresco Labs Inc. logo

Cresco Labs Inc. — Investor Relations & Filings

Ticker · CRLBF ISIN · CA22587M1068 LEI · 549300NSGBTQRF1IBL30 CSE Manufacturing
Filings indexed 243 across all filing types
Latest filing 2025-09-17 Declaration of Voting R…
Country CA Canada
Listing CSE CRLBF

About Cresco Labs Inc.

https://www.crescolabs.com/

Cresco Labs Inc. is a vertically integrated, multistate operator in the cannabis industry, specializing in the cultivation, manufacturing, distribution, and retail sale of medical and adult-use cannabis products. The company manages a portfolio of proprietary brands, including Cresco Cannabis, High Supply, and Mindys Edibles, offering various formats such as flowers, concentrates, and edibles. Cresco Labs distributes its products wholesale and through its national dispensary network, primarily branded Sunnyside, across the United States and Germany. The company focuses on professionalizing the cannabis experience, maintaining high-quality production standards, and promoting industry responsibility through advocacy and community initiatives.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 94% confidence The document is a press release announcing the official voting results of the company’s annual general and special meeting of shareholders, including election of directors and appointment of auditor. This matches the “Declaration of Voting Results & Voting Rights Announcements” category (Code: DVA).
2025-09-17 English
News release - English.pdf
Regulatory Filings Classification · 25% confidence The document is a Business Wire press release announcing the grand opening of a new dispensary location. It contains marketing and operational details, forward‐looking statements, and contact info, but no financial results, governance changes, share transactions, or regulatory filings. It does not fit any specific filing category (e.g., earnings release, annual report, proxy materials, dividend notice, management change, etc.). Under our taxonomy, this type of generic corporate announcement falls into the fallback category for miscellaneous filings: Regulatory Filings (RNS).
2025-09-16 English
Material document(s).pdf
Capital/Financing Update Classification · 92% confidence The document is the full text of a Senior Secured Term Loan Agreement dated August 13, 2025 between Cresco Labs, LLC and a syndicate of lenders, detailing loan definitions, covenants, interest, events of default, security, exhibits and schedules. This is not a brief press announcement or a regulatory filing announcing votes, dividends, or governance matters; it is a comprehensive financing contract establishing new debt facilities. The most appropriate category for a detailed financing arrangement of this nature is Capital/Financing Update (CAP).
2025-09-15 English
Material change report - English.pdf
Capital/Financing Update Classification · 82% confidence The document is a Canadian securities “Material Change Report” (Form 51-102F3) disclosing the closing of a US$325 million senior secured term loan refinancing. This is a specific update on the company’s financing activity and capital structure. It is not simply announcing an upcoming report (so not RPA), nor is it a general regulatory fallback. It directly covers refinancing terms, so it fits the “Capital/Financing Update” category (CAP).
2025-09-15 English
52-109FV2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 80% confidence The document is a Form 52-109FV2 Venture Issuer Basic Certificate certifying the interim financial statements and interim MD&A for the period ended June 30, 2025. It is a regulatory certification filing under Canadian NI 52-109, not the interim report itself nor an announcement of results. It serves as a required regulatory submission. This does not fit any more specific category but aligns with a general regulatory filing.
2025-08-07 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings Classification · 89% confidence The document is a Form 52-109FV2 “Certification of Interim Filings” under Canadian NI 52-109, signed by the CEO certifying the interim financial statements and MD&A for the period ended June 30, 2025. It is a compliance certificate related to interim filings, not the interim report itself, nor an earnings release or management discussion. There is no specific category for certification forms, so it falls under the fallback “Regulatory Filings” category (RNS).
2025-08-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.